Anika Therapeutics, Inc. (ANIK) income statement
ANIKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/30
$13.62+0.77 (+5.99%)
Close on Nov 18, 2026Market cap $182.28MP/E –Yield –
Anika Therapeutics, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 62.2%
- Operating margin
- -4.2%
- Net margin
- -3.1%
- Return on equity, FY2025
- -7.3%
Financial strength
- Current ratio
- 4.48
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 173.4%
Valuation
- P/E ratio
- –
- Price to sales
- 1.51
- Price to book
- 1.33
- Dividend yield
- –
See a number that looks wrong?